Trajan Group Holdings Ltd · ASX:TRJ
Trajan — Shareholder Meeting (October 2026)
35 slides from Trajan's shareholder meeting presentation, Oct 28, 2026
Slide 1: 2026 Annual General Meeting Chair Address and Presentation
Global Corporate Headquarters 7 Argent Place, Ringwood Victoria 3134, Australia For personal use only Tel: +61 (0) 3 9837 4200 www.trajanscimed.com Trajan Group Holdings Limited ACN 152 617 706 ASX RELEASE 2026 Annual General Meeting Chair Address and Presentation 28 October 2026 – Global analytical
Slide 2: Chair's Address
Chair’s Address For personal use only Ladies and gentlemen, fellow shareholders, thank you for joining us today. It is a privilege to welcome you to Trajan’s Annual General Meeting. FY26 was a challenging year for global businesses, including Trajan. In the first quarter we encountered the initial i
Slide 3: Chair's Address (continued)
better reflected over time. Like you, we have been disappointed by the share price. But our response is to stay focused on the fundamentals; building a better business, improving returns, and making sure the market For personal use only has a clearer understanding of the value being created. As we m
Slide 4: 2026 Annual General Meeting
www.trajanscimed.com rsonal use only 2026 Annual General Meeting Wednesday, 28 October 2026
Slide 5: Your Board
YOUR BOARD rsonal use only John Eales AM Stephen Tomisich Robert Lyon Tiffiny Lewin Dr Rohit Khanna Non-Executive Chair Founder, CEO and Executive Executive Director Non-Executive Director Non-Executive Director Director 2
Slide 6: Question Process
QUESTION PROCESS HOW TO ASK A QUESTION rsonal use only • To ask a written question select the Q & A icon • Select the topic your question relates to from the drop-down list • Type your question in the text box and press the send button • To ask a verbal question follow the instructions below the bro
Slide 7: Voting Process
VOTING PROCESS HOW TO VOTE rsonal use only • When the poll is open, select the vote icon at the top of the screen • To vote, select either For, Against or Abstain • You will see a vote confirmation • To change or cancel your vote “click here to change your vote” at any time until the poll is closed
Slide 8: Address by the Chairman
Address by the Chairman Mr John Eales, AM rsonal use only 5
Slide 9: CEO's Presentation
CEO’s Presentation Mr Stephen Tomisich rsonal use only 6
Slide 10: CEO Update
www.trajanscimed.com rsonal use only CEO Update Stephen Tomisich, CEO and Managing Director 28 October 2026
Slide 11: Disclaimer
Disclaimer The material in this presentation is general background information about Trajan Group Holdings Limited (Trajan) and is current at the date of the presentation, 28 October 2026. The information in the presentation is provided for information purposes only, is in summary form and does not
Slide 12: FY2026 Financial Summary
FY2026 Financial Summary KEY POINTS REVENUE & EARNINGS FINANCIAL POSITION • Revenue: Reported revenue declined due to rsonal use only forex volatility. Underlying H2 FY26 revenue was Group Revenue $161.4M Cash $ 12.6M impacted by circa $5.0M due to AUD appreciation. [PCP: $166.5M] Down 3.1% [PCP $11
Slide 13: FY27 begins with promising momentum
FY27 begins with promising momentum FY27 Q1 Update rsonal use only Management accounts* indicate: • nEBITDA momentum has continued with a result of circa $3.5M in the quarter, taking the rolling 12-month nEBITDA to $16.2M • Net revenue** is up 3.8% compared to FY26 Q1 with: • Components & Consumable
Slide 14: Operational Improvement Continues
Operational Improvement Continues As this stage of Project Neptune gains traction, rsonal use only the business becomes leaner and it starts to deliver the intended impact: • Gross Margin, FY27 Q1 proforma %GP above 42%, up 15% on Q1 prior year. • Employee Expense, down 8%+ on Q1 prior year. • Scrap
Slide 15: Resilience in Components & Consumables
Resilience in Components & Consumables Trajan’s largest Business Segment rsonal use only Annualised revenue, at monthly resolution and fixed forex rates, reveals that post destocking (March 2024), growth rate is back to normal. 12
Slide 16: Caution remains about short-term Capital Equipment outlook
Caution remains about short-term Capital Equipment outlook rsonal use only Confidence in the long-term potential, but still rough waters at present Capital Equipment revenues were mostly flat in Q1, and that is against a relatively weak Q1 in the prior year. The opportunity funnel, both food and pha
Slide 17: Science that benefits people: what our customers say
Science that benefits people, here’s what our customers say: Drug discovery for Malaria Treatment monitoring for Epilepsy The University of Dundee's Drug Discovery Unit used Trajan's IRCCS (Bologna, Italy) published a real-world evaluation of HDX and HDExaminer software to develop a new way to Traja
Slide 18: FY27 Guidance
FY27 Guidance Based on the current trajectory and AUD exchange rates we rsonal use only expect in FY27 to achieve: • Net Revenue $162M - $166M. • nEBITDA $16.0M – $17.5M. The mid-point of the revenue projection assumes current FX rates and continued softness in Capital Equipment, hence the 2% implie
Slide 19: Business of the Meeting
rsonal use only Business of the Meeting
Slide 20: Financial Statements and Reports
Item 1 Financial Statements and Reports rsonal use only The first item of business is to receive and consider the Company’s Annual Financial Report, including the Directors’ Report and Audit Report for the year ended 30 June 2026. Note: There is no vote required for this item. 17
Slide 21: Adoption of Remuneration Report
Resolution 1 Adoption of Remuneration Report rsonal use only To consider, and if thought fit, to pass the following resolution as an ordinary resolution: “That, for the purposes of Section 250R(2) of the Corporations Act and for all other purposes, the Remuneration Report as contained in the Directo
Slide 22: Proxy Voting Results - Adoption of Remuneration Report
Proxy Voting Results - Resolution 1 Adoption of Remuneration Report rsonal use only Number %² For 35,235,784 98.99 Against 298,220 0.84 Open – Chair¹ 50,450 0.14 Other 12,000 0.03 Abstain/Exclude 79,862,981 N/A ¹ To be voted in favour of the resolution ² Of proxies cast 19
Slide 23: Re-election of Mr John Eales as a Director
Resolution 2 Re-election of Mr John Eales as a Director rsonal use only To consider, and if thought fit, to pass the following resolution as an ordinary resolution: "That, John Eales, who retires in accordance with clause 12.5 of the Company's Constitution and ASX Listing Rule 14.4 and, being eligib
Slide 24: Proxy Voting Results - Re-election of Mr John Eales
Proxy Voting Results - Resolution 2 Re-election of Mr John Eales as a Director rsonal use only Number %² For 112,978,950 99.08 Against 995,145 0.87 Open – Chair¹ 50,450 0.04 Other 12,000 0.01 Abstain/Exclude 1,422,890 N/A ¹ To be voted in favour of the resolution ² Of proxies cast 21
Slide 25: Re-election of Ms Tiffiny Lewin as a Director
Resolution 3 Re-election of Ms Tiffiny Lewin as a Director rsonal use only To consider, and if thought fit, to pass the following resolution as an ordinary resolution: "That, Tiffiny Lewin, who retires in accordance with clause 12.5 of the Company's Constitution and ASX Listing Rule 14.4 and, being
Slide 26: Proxy Voting Results - Re-election of Ms Tiffiny Lewin
Proxy Voting Results - Resolution 3 Re-election of Ms Tiffiny Lewin as a Director rsonal use only Number %² For 114,481,214 99.16 Against 915,145 0.79 Open – Chair¹ 50,450 0.04 Other 12,000 0.01 Abstain/Exclude 626 N/A ¹ To be voted in favour of the resolution ² Of proxies cast 23
Slide 27: Grant of Options to Director - Mr John Eales
Resolution 4 Grant of Options to Director - Mr John Eales rsonal use only To consider, and if thought fit, to pass the following resolution as an ordinary resolution: "That, subject to the passing of Resolution 2, for the purposes of ASX Listing Rule 10.14 and for all other purposes, Shareholders ap
Slide 28: Proxy Voting Results - Options to Mr John Eales
Proxy Voting Results - Resolution 4 Grant of Options to Director - Mr John Eales rsonal use only Number %² For 35,136,286 96.86 Against 1,116,069 3.08 Open – Chair¹ 11,250 0.03 Other 12,000 0.03 Abstain/Exclude 79,183,830 N/A ¹ To be voted in favour of the resolution ² Of proxies cast 25
Slide 29: Grant of Options to Director - Dr Rohit Khanna
Resolution 5 Grant of Options to Director - Dr Rohit Khanna rsonal use only To consider, and if thought fit, to pass the following resolution as an ordinary resolution: ''That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, Shareholders approve the issue of up to 195,122 Opti
Slide 30: Proxy Voting Results - Options to Dr Rohit Khanna
Proxy Voting Results - Resolution 5 Grant of Options to Director - Dr Rohit Khanna rsonal use only Number %² For 35,142,786 96.88 Against 1,116,069 3.08 Open – Chair¹ 4,750 0.01 Other 12,000 0.03 Abstain/Exclude 79,183,830 N/A ¹ To be voted in favour of the resolution ² Of proxies cast 27
Slide 31: Grant of Options to Director - Ms Tiffiny Lewin
Resolution 6 Grant of Options to Director - Ms Tiffiny Lewin rsonal use only To consider, and if thought fit, to pass the following resolution as an ordinary resolution: "That, subject to the passing of Resolution 3, for the purposes of ASX Listing Rule 10.14 and for all other purposes, Shareholders
Slide 32: Proxy Voting Results - Options to Ms Tiffiny Lewin
Proxy Voting Results - Resolution 6 Grant of Options to Director - Ms Tiffiny Lewin rsonal use only Number %² For 35,136,286 96.88 Against 1,116,069 3.08 Open – Chair¹ 4,750 0.01 Other 12,000 0.03 Abstain/Exclude 79,190,330 N/A ¹ To be voted in favour of the resolution ² Of proxies cast 29
Slide 33: Questions
rsonal use only Questions www.trajanscimed.com
Slide 34: Voting and Meeting Close
Voting and Meeting Close Thank you. rsonal use only If you have not yet voted, please proceed with voting now. The final results of the meeting will be advised to the ASX and will be available on Trajan’s investor website after the meeting. Thank you for your attendance. 31
Slide 35: Thank you
rsonal use only Thank you www.trajanscimed.com 32
Trajan Group Holdings — Shareholder Meeting (October 2026) on 6ix